Tag Archives: LNCE

top rated stock

New Home Sales is a huge gauge for the state of the economy.

The building of the home, the loans for purchasing, the realtors, the upgrades, the decorating, the new furniture and the economic stimulation goes on. If the US New Home Sales report is up, that’s a good sign for the economy and good for currency. The number and news released at 10:00 AM ET, Monday, April 25, 2016, can....More>>>

Top 5 Performing Stocks To Buy Right Now

Donald Trump’s win has done something extraordinary to the financial sector. Just look at this one-month chart for the Financial Select Sector SPDR ETF (XLF):

Banks Love Trump

This is unexpected on two levels.

First, of course, Trump’s very election came as a shock to many. Second, there was no shortage of people saying stocks would tank if the real estate mogul....More>>>

investment risk

When Warren Buffett dissolved his investment partnership in 1969 to focus on Berkshire Hathaway, the company he had acquired a few years earlier, he recommended that his clients invest in the Sequoia Fund (SEQUX). It was great advicefor more than three decades, anyway.

See Also: 5 Good Places to Put Your Money During a Bear Market

When I recommended five low-risk funds to Kiplinger....More>>>

Top 5 Clean Energy Stocks To Watch Right Now

President Trump’s tax returns are unlikely to turn up any Russian connections or impeachable offenses. Sorry, but federal tax returns are not the appropriate documents for that purpose. Members of Congress have offered resolutions demanding Trump’s tax returns and other members have called on him to release them voluntarily.

It was entertaining to watch Rachel Maddow fill an hour....More>>>

top 10 stocks

In spite of being one of worst performing stock in 2016 among the EU Pharma for the uncertainties related to the acquisition of Monsanto, I would not chase Bayer (OTCPK:BAYZF, OTCPK:BAYRY) in 2017, because I think the valuation is fully reflecting the strengths and opportunities of the company.

I like Bayer’s long-term strategy and diversification approach, with exposure to pharmaceuticals....More>>>